Prohibiting MG53 Phosphorylation Optimizes its Therapeutic Potential in Diabetes

Circ Res. 2022 Dec 2;131(12):977-979. doi: 10.1161/CIRCRESAHA.122.322132. Epub 2022 Dec 1.

Authors

Duane D Hall¹, Qian Shi¹, Long-Sheng Song¹

Affiliation

¹ Division of Cardiovascular Medicine, Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus* / therapy
Humans
Phosphorylation

Grants and funding